CN Patent

CN103260625A — 用于治疗肝脏疾病的ibat抑制剂

Assigned to Albireo AB · Expires 2013-08-21 · 13y expired

What this patent protects

本发明涉及用于预防和/或治疗肝病的特异性IBAT抑制剂。本发明还涉及包含这些IBAT抑制剂的组合物，治疗这些病症的方法以及包含这些物质或这些组合物的试剂盒。

USPTO Abstract

本发明涉及用于预防和/或治疗肝病的特异性IBAT抑制剂。本发明还涉及包含这些IBAT抑制剂的组合物，治疗这些病症的方法以及包含这些物质或这些组合物的试剂盒。

Drugs covered by this patent

Patent Metadata

Patent number
CN103260625A
Jurisdiction
CN
Classification
—
Expires
2013-08-21
Drug substance claim
No
Drug product claim
No
Assignee
Albireo AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.